TRAX (First Tracks Biotherapeutics) Other Current Payables: $0.00 Mil (As of Dec. 2024)


TRAX First Tracks Biotherapeutics Inc TRAX
12 GF Score
Price $36.24
! 3 Warning Signs
View Full Analysis

What is First Tracks Biotherapeutics Other Current Payables?

First Tracks Biotherapeutics TRAX +11.85% 12 Other Current Payables is $0.00 Mil as of Dec. 2024. GuruFocus rates TRAX with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

First Tracks Biotherapeutics's Other Current Payables for the quarter that ended in Dec. 2024 was $0.00 Mil.

First Tracks Biotherapeutics Other Current Payables Related Terms

First Tracks Biotherapeutics Other Current Payables Historical Data

* Premium members only.

The historical data trend for First Tracks Biotherapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

First Tracks Biotherapeutics Other Current Payables Chart

First Tracks Biotherapeutics Annual Data
Trend Dec23 Dec24
Other Current Payables
0.00 0.00

First Tracks Biotherapeutics Semi-Annual Data
Dec23 Dec24
Other Current Payables 0.00 0.00
TRAX
12GF Score
First Tracks Biotherapeutics Inc TRAX
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

First Tracks Biotherapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
First Tracks Biotherapeutics (TRAX) has a Other Current Payables of $0.00 Mil as of Dec. 2024. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on First Tracks Biotherapeutics and its competitors.
Is First Tracks Biotherapeutics' Other Current Payables too high?
First Tracks Biotherapeutics' current Other Current Payables is $0.00 Mil. Overall, First Tracks Biotherapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does First Tracks Biotherapeutics' Other Current Payables compare to ALT and RGNX?
First Tracks Biotherapeutics' Other Current Payables of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on First Tracks Biotherapeutics and its competitors. First Tracks Biotherapeutics's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is First Tracks Biotherapeutics stock overvalued right now?
First Tracks Biotherapeutics (TRAX) has a current Other Current Payables of $0.00 Mil. The current Other Current Payables is $0.00 Mil. First Tracks Biotherapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For First Tracks Biotherapeutics (TRAX), the current Other Current Payables is $0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

First Tracks Biotherapeutics Business Description

Other Exchanges B43:Germany
Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
12GF Score

Get the complete analysis for TRAX

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$36.24
Price